Barbara Hero
Impact in
- Neurology top 0.05%
- Neuroblastoma Research and Treatments
- Neurofibromatosis and Schwannoma Cases
- Cancer Research top 0.5%
- Cancer, Hypoxia, and Metabolism
Papers in
- Neurology 139
- Neuroblastoma Research and Treatments 134
- Autoimmune Neurological Disorders and Treatments 9
-
- Cancer therapeutics and mechanisms 18
- Co-authors
- Frank Berthold (108 shared papers)Thorsten Simon (61 shared papers)Matthias Fischer (28 shared papers)Frank Westermann (16 shared papers)Andreas Faldum (10 shared papers)Katherine K. Matthay (7 shared papers)Wendy B. London (8 shared papers)Andrew D.J. Pearson (9 shared papers)
- Journals
- Journal of Clinical Oncology (14 papers)Pediatric Blood & Cancer (13 papers)European Journal of Cancer (12 papers)Clinical Cancer Research (10 papers)Cancer (5 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Barbara Hero
167 papers receiving 8.3k citations
Barbara Hero's Hit Papers
Peers
Comparison fields: 5 of 115
- Neurology 6.0k
- Cancer Research 1.7k
- Oncology 1.2k
- Genetics 452
- Molecular Biology 2.8k
Countries citing papers authored by Barbara Hero
This map shows the geographic impact of Barbara Hero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Hero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Hero more than expected).
Fields of papers citing papers by Barbara Hero
This network shows the impact of papers produced by Barbara Hero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Hero. The network helps show where Barbara Hero may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Hero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 171 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The International Neuroblastoma Risk Group (INRG) Classification System: An INRG Task Force Report Hit paper breakdown → | 2008 | 1284 |
| 2 | 2008 | 323 | |
| 3 | 2011 | 301 | |
| 4 | 2005 | 276 | |
| 5 | 2002 | 242 | |
| 6 | 2003 | 233 | |
| 7 | 2001 | 232 | |
| 8 | 2006 | 200 | |
| 9 | 2008 | 192 | |
| 10 | 2008 | 185 | |
| 11 | 2013 | 164 | |
| 12 | 2004 | 150 | |
| 13 | 2014 | 136 | |
| 14 | 2004 | 108 | |
| 15 | 2005 | 103 | |
| 16 | 2011 | 100 | |
| 17 | 2014 | 98 | |
| 18 | Deletions in chromosome arms 3p and 11q are new prognostic markers in localized and 4s neuroblastoma. | 2003 | 96 |
| 19 | 2010 | 95 | |
| 20 | 2021 | 91 |
About Barbara Hero
Barbara Hero is a scholar working on Neurology, Molecular Biology, Cancer Research, Oncology and Surgery, having authored 171 papers that have together received 8.4k indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (134 papers), Cancer, Hypoxia, and Metabolism (26 papers), Cancer therapeutics and mechanisms (18 papers), Lung Cancer Research Studies (10 papers), Autoimmune Neurological Disorders and Treatments (9 papers), Neuroendocrine Tumor Research Advances (9 papers), Adrenal and Paraganglionic Tumors (6 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Neurology (6.0k citations), Cancer Research (1.7k citations), Oncology (1.2k citations), Genetics (452 citations) and Molecular Biology (2.8k citations). Barbara Hero has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Frank Berthold, Thorsten Simon, Matthias Fischer, Frank Westermann, Andreas Faldum, Katherine K. Matthay, Wendy B. London, Andrew D.J. Pearson, Susan L. Cohn and Tom Monclair. Their work appears in journals such as Journal of Clinical Oncology, Pediatric Blood & Cancer, European Journal of Cancer, Clinical Cancer Research and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.